SG Americas Securities LLC Grows Position in Alignment Healthcare, Inc. $ALHC

SG Americas Securities LLC boosted its holdings in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 148.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 60,390 shares of the company’s stock after acquiring an additional 36,084 shares during the quarter. SG Americas Securities LLC’s holdings in Alignment Healthcare were worth $1,193,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of ALHC. Larson Financial Group LLC purchased a new position in Alignment Healthcare in the third quarter worth $33,000. GAMMA Investing LLC increased its position in shares of Alignment Healthcare by 83.8% in the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock valued at $43,000 after buying an additional 987 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new position in shares of Alignment Healthcare in the third quarter valued at $53,000. PNC Financial Services Group Inc. increased its position in shares of Alignment Healthcare by 205.6% in the third quarter. PNC Financial Services Group Inc. now owns 3,459 shares of the company’s stock valued at $60,000 after buying an additional 2,327 shares in the last quarter. Finally, Allworth Financial LP increased its position in shares of Alignment Healthcare by 28.3% in the third quarter. Allworth Financial LP now owns 6,351 shares of the company’s stock valued at $111,000 after buying an additional 1,402 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Analyst Upgrades and Downgrades

ALHC has been the subject of a number of research analyst reports. JPMorgan Chase & Co. raised their price target on Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Piper Sandler raised their price target on Alignment Healthcare from $20.00 to $30.00 and gave the company an “overweight” rating in a research report on Tuesday, January 6th. Robert W. Baird set a $28.00 price target on Alignment Healthcare in a research report on Friday, January 30th. Wall Street Zen cut Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, March 7th. Finally, KeyCorp restated an “overweight” rating and issued a $28.00 price target on shares of Alignment Healthcare in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $24.75.

Insider Activity

In related news, COO Sebastian Burzacchi sold 15,361 shares of Alignment Healthcare stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $17.84, for a total transaction of $274,040.24. Following the completion of the sale, the chief operating officer owned 258,630 shares in the company, valued at approximately $4,613,959.20. This trade represents a 5.61% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Andreas P. Wagner sold 11,602 shares of Alignment Healthcare stock in a transaction dated Thursday, March 19th. The stock was sold at an average price of $18.22, for a total value of $211,388.44. Following the sale, the insider owned 148,628 shares of the company’s stock, valued at approximately $2,708,002.16. This represents a 7.24% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 1,094,997 shares of company stock worth $20,879,431 in the last quarter. Corporate insiders own 7.00% of the company’s stock.

Alignment Healthcare Trading Up 16.0%

Alignment Healthcare stock opened at $21.66 on Wednesday. The stock has a market cap of $4.43 billion, a PE ratio of -2,163.84, a P/E/G ratio of 2.74 and a beta of 1.20. The stock has a 50-day moving average price of $19.37 and a 200 day moving average price of $18.96. Alignment Healthcare, Inc. has a 52 week low of $11.63 and a 52 week high of $23.87. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.80.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.10. The firm had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The firm’s quarterly revenue was up 44.4% compared to the same quarter last year. During the same quarter last year, the business posted ($0.16) EPS. Equities research analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.